Alpha 2.0
Login Register
» Articles » PMID: 17552112

Clostridium Difficile-associated Disease in New Jersey Hospitals, 2000-2004

Overview
Journal Emerg Infect Dis
Specialty Infectious Diseases
Date 2007 Jun 8
PMID 17552112
Citations 4
Authors
Esther T Tan
Corwin A Robertson
Shereen Brynildsen
Eddy Bresnitz
Christina Tan
Clifford McDonald
Affiliations
Soon will be listed here.
Abstract

Recent emergence of a virulent strain of Clostridium difficile demonstrates the importance of tracking C. difficile incidence locally. Our survey of New Jersey hospitals documented increases in the rates of C. difficile disease (by 2-fold), C. difficile-associated complications (by 7-fold), and C. difficile outbreaks (by 12-fold) during 2000-2004.

Citing Articles

Global burden of infections: a systematic review and meta-analysis.

Balsells E, Shi T, Leese C, Lyell I, Burrows J, Wiuff C J Glob Health. 2019; 9(1):010407.

PMID: 30603078 PMC: 6304170. DOI: 10.7189/jogh.09.010407.

Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection.

Boone J, DiPersio J, Tan M, Salstrom S, Wickham K, Carman R Eur J Clin Microbiol Infect Dis. 2013; 32(12):1517-23.

PMID: 23771554 PMC: 3825630. DOI: 10.1007/s10096-013-1905-x.

The changing epidemiology of Clostridium difficile infections.

Freeman J, Bauer M, Baines S, Corver J, Fawley W, Goorhuis B Clin Microbiol Rev. 2010; 23(3):529-49.

PMID: 20610822 PMC: 2901659. DOI: 10.1128/CMR.00082-09.

Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital.

Salazar M, Garey K, Jiang Z, Dao-Tran T, DuPont H Pharm World Sci. 2009; 31(5):565.

PMID: 19657721 DOI: 10.1007/s11096-009-9316-x.

References
1.
Haley R, Culver D, White J, Morgan W, Emori T, Munn V . The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985; 121(2):182-205. DOI: 10.1093/oxfordjournals.aje.a113990. View
2.
. Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR Morb Mortal Wkly Rep. 1992; 41(42):783-7. View
3.
Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T . Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med. 1996; 156(13):1449-54. View
4.
Scheckler W, Brimhall D, BUCK A, Farr B, Friedman C, Garibaldi R . Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: A consensus panel report. Society for Healthcare Epidemiology of America. Am J Infect Control. 1998; 26(1):47-60. DOI: 10.1016/s0196-6553(98)70061-6. View
5.
Archibald L, Banerjee S, Jarvis W . Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis. 2004; 189(9):1585-9. DOI: 10.1086/383045. View